Ambulatory surgery center market seen reaching $113.36 billion by 2030

The ambulatory surgery center market is forecast to grow from $88.66 billion in 2025 to $113.36 billion by 2030 as more procedures move to outpatient settings. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Ambulatory surgery centers are becoming a bigger part of outpatient care as providers look for lower-cost, more efficient alternatives to hospital-based surgery. - The market’s projected climb to $113.36 billion by 2030 signals sustained demand for facilities built around faster scheduling, specialized staff and procedure-specific equipment. - Growth in minimally invasive and robotic-assisted procedures is reinforcing the shift toward outpatient surgical care.

What happened: - The Business Research Company published its Ambulatory Surgery Center Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - The report says the market will rise from $88.66 billion in 2025 to $93.25 billion in 2026, reflecting a 5.2% CAGR. - The market is projected to reach $113.36 billion by 2030, growing at a 5.0% CAGR. - North America held the largest share of the ambulatory surgery center market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Ambulatory surgery centers are outpatient facilities designed for surgical care, diagnostic services and preventive services. - These centers aim to improve the outpatient experience through flexible scheduling, specially trained staff and equipment tailored to specific procedures. - The report links recent growth to a higher volume of surgical procedures, a shift from hospitals to ASCs, lower-cost surgical care, physician-owned centers and specialized outpatient equipment. - The report identifies robotic-assisted outpatient surgeries, investment in high-efficiency surgical facilities, expansion in orthopedic and ophthalmic procedures, patient preference for convenience and bundled payment models as key drivers of future growth. - The report points to minimally invasive surgeries, freestanding ASCs, specialty-focused centers, advanced surgical technology and operational efficiency as major trends. - The report says the market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report’s updated 2026 materials include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - The American Society of Plastic Surgeons reported in June 2024 that minimally invasive procedures rose 7% in 2023, outpacing surgical procedures by 2%. - Neuromodulator injections topped 9 million treatments, while hyaluronic acid fillers exceeded 5 million treatments, underscoring rising demand for outpatient procedures. - The report is available with a free sample and the full market report.

Between the lines: - The forecast suggests outpatient surgery is still taking share from inpatient settings as healthcare systems prioritize speed, cost control and higher throughput. - Growth in specialty procedures such as orthopedics and ophthalmology points to ASCs becoming more specialized, not just more numerous. - The regional outlook suggests mature markets will remain large, while faster adoption in Asia-Pacific could reshape where new ASC investment flows.

What's next: - The market is expected to keep expanding through 2030 as outpatient surgery adoption widens and facilities invest in more advanced procedures and technology. - Continued growth in minimally invasive and robotic-assisted surgery could further increase demand for freestanding ASCs and specialty centers. - The Business Research Company is positioning its 2026 report as a planning tool for companies tracking market hotspots, technology shifts and forecast changes.

The bottom line: - Ambulatory surgery centers are on a steady growth path, with demand supported by lower-cost outpatient care, rising procedure volumes and a broader shift away from hospital-based surgery.